In Vivo Evaluation of an Oral Salmon Calcitonin-Delivery System Based on a Thiolated Chitosan Carrier Matrix

Pharmaceutical Research

Volumn 20, Issue 12, 2003, Pages 1989-1994

  Guggi, Davide ^a   Kast, Constantia E ^a   Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Controlled release; Enzyme inhibitors; Oral delivery system; Reduced glutathione; Salmon calcitonin; Thiolated polymer

Indexed keywords

2 IMINOTHIOLANE; BOWMAN BIRK INHIBITOR; CALCIUM; CHITOSAN; CHITOSAN 4 THIOBUTYLAMIDE; DRUG CARRIER; ENZYME INHIBITOR; GLUTATHIONE; MANNITOL; POLYMETHACRYLIC ACID; SALCATONIN; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; CHEMICAL COMPOSITION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; COVALENT BOND; DRUG ABSORPTION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; ENTERIC COATED TABLET; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOLOGICAL AVAILABILITY; CALCITONIN; CHEMISTRY, PHARMACEUTICAL; CHITIN; CHITOSAN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; GLUTATHIONE; MALE; RATS; RATS, WISTAR; SOLUBILITY; TABLETS; TRYPSIN INHIBITOR, BOWMAN-BIRK SOYBEAN;

EID: 0348026751     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000008047.82334.7d     Document Type: Article

References (28)

1. Y.-H. Lee and P. J. Sinko. Oral delivery of salmon calcitonin. Adv. Drug Deliv. Rev. 42:225-238 (2000).
2. M. Torres-Lugo and N. A. Peppas. Transmucosal delivery systems for calcitonin: a review. Biomaterials 21:1191-1196 (2000).
3. A. Bernkop-Schnürch. The use of inhibitory agents to overcome the enzymatic barrier to perorally administered therapeutic peptides and proteins. J. Cont. Rel. 52:1-16 (1998).
4. H. Takeuchi, H. Yamamoto, T. Niwa, T. Hino, and Y. Kawashima. Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm. Res. 13:896-901 (1996).
5. E. Mathiowitz, J. S. Jacob, Y. S. Jong, G. P. Carino, D. E. Chickering, P. Chaturvedi, C. A. Santos, K. Vijayaraghavan, S. Montgomery, M. Bassett, and C. Morrell. Biologically erodable microspheres as potential oral drug delivery systems. Nature 386:410-414 (1997).
6. A. Rubinstein, B. Tirosh, M. Baluom, T. Nassar, A. David, I. Gliko-Kabir, R. Radai, and M. Friedman. The rationale for peptide drugs delivery to the colon and the potential of polymeric carriers as effective tools. J. Cont. Rel. 46:59-73 (1997).
7. A. Bernkop-Schnürch, G. H. Schwarz, and M. Kratzel. Modified mucoadhesive polymers for the peroral administration of mainly elastase degradable therapeutic (poly)peptides. J. Cont. Rel. 47:113-121 (1997).
8. M. K. Marschütz, P. Caliceti, and A. Bernkop-Schnürch. Design and in vivo evaluation of an oral delivery system for insulin. Pharm. Res. 17:1468-1474 (2000).
9. C. E. Kast, D. Guggi, N. Langoth, and A. Bernkop-Schnürch. Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil. Pharm. Res. 20:931-936 (2003).
10. A. Bernkop-Schnürch, V. Schwarz, and S. Steininger. Polymers with thiol groups: a new generation of mucoadhesive polymers? Pharm. Res. 16:876-881 (1999).
11. A. Bernkop-Schnürch, M. Hornof, and T. Zoidl. Thiolated polymers-Thiomers: modification of chitosan with 2-iminothiolane. Int. J. Pharm. 260:229-237 (2003).
12. D. Guggi and A. Bernkop-Schnürch. In vitro evaluation of polymeric excipients protecting calcitonin against degradation by intestinal serine proteases. Int. J. Pharm. 252:187-196 (2003).
13. A. E. Clausen, C. E. Kast, and A. Bernkop-Schnürch. The role of glutathione in the permeation enhancing effect of thiolated polymers. Pharm. Res. 19:602-608 (2002).
14. M. K. Marschütz and A. Bernkop-Schnürch. Oral peptide drug delivery: polymer-inhibitor conjugates protecting insulin from enzymatic degradation in vitro. Biomaterials 21:1499-1507 (2000).
15. M. Baluom, D. I. Friedman, and A. Rubinstein. Absorption enhancement of calcitonin in the rat intestine by carbopol-containing submicron emulsions. Int. J. Pharm. 154:235-243 (1997).
16. Y. Watanabe, M. Y., A. Kubomura, M. Kiriyama, N. Utoguchi, and M. Matsumoto. Studies of drug delivery systems for therapeutic agent used in osteoporosis. I. Pharmacodynamic (hypocalcemic effect) of elcatonin in rabbits following rectal administration of hollow-type suppositories containing elcatonin. Biol. Pharm. Bull. 21:1187-1190 (1998).
17. A. Bernkop-Schnürch, S. Scholler, and R. G. Biebel. Development of controlled drug release systems based on thiolated polymers. J. Cont. Rel. 66:39-48 (2000).
18. J. F. Sigurjónsdóttir, T. Loftsson, and M. Másson. Influence of cyclodextrins on the stability of the peptide salmon calcitonin in aqueous solution. Int. J. Pharm. 186:205-213 (1999).
19. Y. Kawashima, H. Yamamoto, H. Takeuchi, and Y. Kuno. Mucoadhesive DL-lactide/glycolide copolymer nanospheres coated with chitosan to improve oral delivery of elcatonin. Pharm. Dev. Technol. 5:77-85 (2000).
20. C. M. Lehr, F. G. J. Poelma, H.E. Junginger, and J. J. Tukker. An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop. Int. J. Pharm. 70:235-240 (1991).
21. J. F. Forstner. Intestinal mucins in health and disease. Digestion 17:234-263 (1978).
22. A. Allen, D. A. Hutton, J. P. Pearson, and L. A. Sellers. Mucus glycoprotein structure, gel formation and gastrointestinal mucus function. Ciba Found. Symp. 109:137-156 (1984).
23. N. G. M. Schipper, K.M. Varum, P. Stenberg, G. Ocklind, H. Lennernäs, and P. Artursson. Chitosans as absorption enhancers for poorly absorbable drugs. 3: Influence of mucus on absorption enhancement. Eur. J. Pharm. Sci. 8:335-343 (1999).
24. G. Ranaldi, I. Marigliano, I. Vespignani, G. Perozzi, and Y. Sambuy. The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line(1). J. Nutr. Biochem. 13:157-167 (2002).
25. O. Felt, P. Buri, and R. Gurny. Chitosan: a unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm. 24:979-993 (1998).
26. H. L. Luessen, B. J. de Leeuw, M. W. Langemeyer, A. G. de Boer, J. C. Verhoef, and H. E. Junginger. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm. Res. 13:1668-1672 (1996).
27. M. Thanou, J. C. Verhoef, J. H. Verheijden, and H. E. Junginger. Intestinal absorption of octreotide using trimethy chitosan chloride: studies in pigs. Pharm. Res. 18:823-828 (2001).
28. A. Bernkop-Schnürch, U. M. Brandt, and A. E. Clausen. Synthesis and in vitro evaluation of chitosan-cysteine conjugates. Sci. Pharm. 67:196-208 (1999).